Eikon Therapeutics, Inc. Common Stock (EIKN) — Net Asset Quality Index
Eikon Therapeutics, Inc. Common Stock (EIKN) has a Net Asset Quality Index of -147.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $594.73 Million minus total liabilities of $1.47 Billion yields net assets of $-879.03 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Eikon Therapeutics, Inc. Common Stock to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Eikon Therapeutics, Inc. Common Stock Net Asset Quality Index Over Time (2023–2025)
This chart shows how Eikon Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the index stands at -147.8%, representing net assets of $-879.03 Million against total assets of $594.73 Million USD. See Eikon Therapeutics, Inc. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Eikon Therapeutics, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Net Asset Quality Index for Eikon Therapeutics, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see EIKN company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -147.8% | $-879.03 Million | $594.73 Million | $1.47 Billion | ▼ -31.4 pp |
| 2024 | -116.4% | $-571.93 Million | $491.24 Million | $1.06 Billion | ▼ -51.5 pp |
| 2023 | -64.9% | $-341.37 Million | $525.71 Million | $867.08 Million | — |